Deals
Licensing ×
May 2022
A subsidiary of Servier
has divested its anti-LAG-3 monoclonal antibody to
A subsidiary of Sino Biopharmaceutical Limited
Mar 2021
has licensed the patents and know-how to its Crystalomics Formulation Technology to
